Patents by Inventor Meucci Ilunga

Meucci Ilunga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12552834
    Abstract: Peptides that selectively bind ENAH (MENA) are described. The peptides are useful for treating certain cancers, such as triple negative breast cancer and for reducing resistance to taxane therapy.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: February 17, 2026
    Assignees: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Theresa Hwang, Amy E. Keating, Meucci Ilunga, Sara Parker, Ghassan Mouneimne, Samantha Hill
  • Publication number: 20240101604
    Abstract: Peptides that selectively bind ENAH (MENA) are described. The peptides are useful for treating certain cancers, such as triple negative breast cancer and for reducing resistance to taxane therapy.
    Type: Application
    Filed: January 25, 2022
    Publication date: March 28, 2024
    Inventors: Theresa Hwang, Amy E. Keating, Meucci Ilunga, Sara Parker, Ghassan Mouneimne, Samantha Hill